NeuroFrontiers

Host: Jerome Lisk, MD, MBA, M.S., FAAN Guest: Jerrold Vitek, MD, PhD What is deep brain stimulation, and how is this technology helping patients with conditions like Parkinson's disease and epilepsy? Tune in to hear Dr. Jerome Lisk speak with Dr. Jerrold Vitek about current and future applications of this technology.

Host: David Weisman, MD Guest: Adil Javed, MD, PhD How can providers help mitigate the symptoms of a disease as debilitating as multiple sclerosis? Dr. David Weisman examines management strategies for patients with multiple sclerosis with is Dr. Adil Javed, a board-certified neurologist and an Associate Professor of Neurology at the University of Chicago.

Host: Andrew Wilner, MD, FACP, FAAN Guest: Jennifer Frontera, MD Although the impact of COVID-19 can be long-lasting, many have had similar effects, even if they aren’t diagnosed with the disease. Dr. Jennifer Frontera, a neurocritical care specialist and professor of neurology at the NYU Grossman School of Medicine, shares some insight on the neurological symptoms that patients with COVID-19 are...

Host: Jerome Lisk, MD, MBA, M.S., FAAN Guest: Ilan Wittstein, MD With no standard criteria available, how do we detect broken heart syndrome in our patients? Dr. Ilan Wittstein, the Director of the Advanced Heart Failure Fellowship and Assistant Professor of Medicine at Johns Hopkins School of Medicine, shares what we should be looking for.

Host: Andrew Wilner, MD, FACP, FAAN Guest: Jennifer Frontera, MD Most commonly associated with respiratory symptoms, COVID-19 infections have led to a myriad of neurological symptoms such as encephalopathy and stroke. Dr. Andrew Wilner joins Dr. Jennifer Frontera, a neurocritical care specialist and professor of neurology at the NYU Grossman School of Medicine, to discuss obstacles that neurologis...

Host: David Weisman, MD Guest: Mijail D Serruya MD,PhD Thousands of Americans live with the debilitating aftereffects of stroke, such as arm and communication problems. This makes technological developments like brain-computer interfaces absolutely critical for stroke survivors, but some questions are beginning to arise regarding the ethics of this technology. So in order for us to fully pursue th...

Host: David Weisman, MD Guest: Mijail D Serruya MD,PhD Every 40 seconds: that’s how often someone in the United States has a stroke. And it’s not uncommon for many of these patients to experience impaired functionality for the rest of their lives. But now, thanks to the latest technology, could something that seems straight out of a science-fiction novel like brain-computer interfaces help us impr...

Host: Jerome Lisk, MD, MBA, M.S., FAAN Guest: Eric Gantwerker, MD, MMSc, FACS The rise of gaming in medical education has become a much bigger and faster-moving phenomenon than we may know. To find out more, Dr. Jerome Lisk is joined by Dr. Eric Gantwerker from Level EX, which develops video games that are designed to improve clinical decision-making skills. Together, they talk about the evolving...

Host: Andrew Wilner, MD, FACP, FAAN Guest: Ken Tyler, MD Further complicating the COVID-19 pandemic is the emergence of viral variants. Dr. Ken Tyler from the University of Colorado School of Medicine shares with us what we know so far about the COVID-19 variants that are quickly spreading around the world.

Host: Andrew Wilner, MD, FACP, FAAN Guest: Ken Tyler, MD To find out what we currently know about the neurological complications caused by COVID-19, Dr. Andrew Wilner speaks with Dr. Ken Tyler, Professor and Chair of the Department of Neurology at the University of Colorado School of Medicine.

Host: Jerome Lisk, MD, MBA, M.S., FAAN Guest: Anthony L. Fine, M.D Recent advancements in the field of fetal neurology have equipped clinicians to detect neurological diseases before the child is even born. Dr. Jerome Lisk joins Dr. Anthony Fine, a pediatric neurologist and epileptologist at Mayo Clinic in Rochester, to discuss some of these advancements.

Host: Anthony Alessi, MD Guest: Lynn Taylor, MD Meningiomas were in the news this spring after actress Mary Tyler Moore had a tumor removed from her brain. Ninety percent of meningiomas are benign, many are asymptomatic, and some are so slow-growing they go undiagnosed. But many are discovered as an incidental finding in patients with headache. How do we treat patients diagnosed with meningiomas?...

Host: Anthony Alessi, MD Guest: Jeffrey Kutcher, MD, FAAN Most athletes' concussions are not the result of the kind of hits that NFL players take, but they still need to be taken very seriously. The American Academy of Neurology now recommends all athletes suspected of a concussion be removed from the field immediately. Dr. Jeffrey Kutcher, director of Michigan NeuroSport, the sports neurology pro...

Host: Anthony Alessi, MD Guest: Vera Bril, MD At least half of diabetic patients will experience neuropathy some time in their life, but many of these patients never discuss the painful condition with their doctor. When a patient does complain of burning or electric shock sensations in their feet and hands, how should they be treated? Dr. Vera Bril, professor of neurology at the University of Toro...

Host: Anthony Alessi, MD Guest: Neil Busis, MD Is there an app for helping your patients improve their health? In fact, there are many. Dr. Neil Busis, chief of the division of neurology, department of medicine, at University of Pittsburgh Medical Center Shadyside and Practice and Technology editor of AAN.com, talks with host Dr. Anthony Alessi about the latest mobile technologies used to monitor...

Host: Anthony Alessi, MD Guest: Lisa Shulman Would it be better for Parkinson's patients to meet with their doctor in a group setting? Group visits are among the the novel approaches being studied for Parkinson's patients. Dr. Lisa Shulman, professor of neurology and co-director of the Maryland Parkinson's Disease and Movement Disorders Center in Baltimore, joins host Dr. Anthony Alessi to discuss...

Host: Anthony Alessi, MD Guest: Ronald DeVere, MD Smell and taste loss can be the first sign of a serious neurologic disorder like Parkinson's or Alzheimer's disease, but it is also possible to lose these senses after something as simple as a sinus infection or virus. How can you help your patients get to the bottom of why this is happenning to them, and how can you help them cope with this change...

Host: Anthony Alessi, MD Guest: Jeffrey Cohen, MD For years, patients with multiple sclerosis have had to rely on injectable medications. But several new oral medications are emerging, and one drug has already been approved by the FDA. Why has it taken so long to develop oral formulations? Dr. Jeffrey Cohen, director of the Millen Experimental Therapeutics program at the Cleveland Clinic and profe...

Host: Anthony Alessi, MD Guest: Eelco Wijdicks, MD, PhD The American Academy of Neurology released new guidelines for determining brain death in adults, providing a step-by-step process for making this decision consistent among hospitals in the United States. One major departure in these guidelines is the recommendation of a single exam, rather than multiple exams occurring at several-hour interva...

Host: Anthony Alessi, MD Guest: Carl Ansevin, MD For the 12 million Americans who suffer from restless leg syndrome (RLS), the disease can often be misdiagnosed and misunderstood. Doctors as well as their patients are now more familiar with RLS due to the intense marketing of drugs used to treat restless legs syndrome. Host Dr. Anthony Alessi talks with Dr. Carl Ansevin, an adjunct faculty member...

Host: Anthony Alessi, MD Guest: William Coplin, MD The world witnessed a remarkable recovery after Congresswoman Gabrielle Giffords was shot in the head in an assassination attempt in January, 2011. However, most gunshot wounds to the head are fatal; statistics show only 5 percent of those shot in the head survive. Yet there are actions first responders and physicians can take to increase the chan...

Host: Anthony Alessi, MD Guest: David Simpson, MD 14 million Americans suffer migraine headaches every day. Many go untreated and many who are treated continue to have headaches. But an old drug proved to offer a new way to treat migraines, with the FDA approval of botulinum toxin injections for severe chronic migraine. Dr. David Simpson, professor of neurology at Mount Sinai School of Medicine in...

Host: Anthony Alessi, MD Guest: Don Iverson, MD Nationwide there are an estimated several hundred thousand licensed drivers with Alzheimer's disease. A new study shows that more than half can still pass a road test, leaving physicians to help patients and caregivers decide when it's time to stop driving. Dr. Donald Iverson, lead author of the American Academy of Neurology's most recent guidelines...

Host: Anthony Alessi, MD Guest: Mill Etienne, MD, MPH, CPH Host Dr. Anthony Alessi interviews neurologist Lt. Cmdr. Mill Etienne, MD, at St. Damien's Pediatric Hospital in Port-au-Prince, Hati. Dr. Etienne is a Hatian-American physician in the United States military, stationed on the USNS Comfort. They discuss Dr. Etienne's work providing medical care, in addition to translation services and cultu...

Host: Anthony Alessi, MD Guest: James Sejvar, MD How is the CDC monitoring neurological complications from the H1N1 vaccine as it relates to the risk of Guillain-Barre syndrome? Dr. James Sejvar, neuroepidemiologist in the division of viral and rickettsial diseases at the National Center for Infectious Diseases and the Center for Disease Control and Prevention, outlines for host Dr. Anthony Alessi...